Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -11.94x is 147% below its 5-year average of -4.84x, near the low end of its 5-year range (-11.94x–-1.20x).
As of the fiscal period ended Sunday, December 31, 2023.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2023 (2023-12-31): -11.94x.
INTEREST COVERAGE RATIO
-11.94x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
-4.84x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
-146.78%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 520 covered companies
CURRENT VS SECTOR MEDIAN
-87.28%
vs the sector median at left
Passage Bio, Inc.
Market Cap
$12.95M
Interest Coverage Ratio
-11.94x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
-4.84x
Market Cap
$12.54M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.66M
Interest Coverage Ratio
-5.45x
TTM Avg
0.92x
3Y Avg
0.92x
5Y Avg
0.92x
Market Cap
$12.69M
Interest Coverage Ratio
-1171.55x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.57M
Interest Coverage Ratio
-16.47x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.54M
Interest Coverage Ratio
-128.38x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$13.51M
Interest Coverage Ratio
-8.52x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$13.50M
Interest Coverage Ratio
-143.87x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Passage Bio, Inc. (PASG) | $12.95M | -11.94x | N/A | N/A | -4.84x |
| Cellectar Biosciences, Inc. (CLRB)vs › | $12.54M | N/A | N/A | N/A | N/A |
| IN8bio, Inc. (INAB)vs › | $13.14M | N/A | N/A | N/A | N/A |
| Cytosorbents Corporation (CTSO)vs › | $12.66M | -5.45x | 0.92x | 0.92x | 0.92x |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $12.69M | -1171.55x | N/A | N/A | N/A |
| Dare Bioscience, Inc. (DARE)vs › | $12.57M | -16.47x | N/A | N/A | N/A |
| Tempest Therapeutics, Inc. (TPST)vs › | $12.54M | -128.38x | N/A | N/A | N/A |
| Optimi Health Corp. (OPTH)vs › | $13.51M | -8.52x | N/A | N/A | N/A |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.50M | -143.87x | N/A | N/A | N/A |
| Lantern Pharma Inc. (LTRN)vs › | $12.28M | N/A | N/A | N/A | N/A |
Interest Coverage
-11.9x
Debt/Equity
0.00
Current Ratio
1.22
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2023-12-31 | -11.94x |
| 2019-06-30 | -1.37x |
| 2019-03-31 | -1.20x |
